BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30948501)

  • 1. GHET1 acts as a prognostic indicator and functions as an oncogenic lncRNA in cervical cancer.
    Zhang Q; Zhang Y; Wang Y
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30948501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINC00511 is associated with the malignant status and promotes cell proliferation and motility in cervical cancer.
    Yu CL; Xu XL; Yuan F
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31434692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
    Song R; Zhang J; Huang J; Hai T
    Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of LncRNA GHET1 predicts an unfavourable survival and clinical parameters of patients in various cancers.
    Jiang YF; Zhang HY; Ke J; Shen H; Ou HB; Liu Y
    J Cell Mol Med; 2019 Aug; 23(8):4891-4899. PubMed ID: 31251476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA GHET1 promotes esophageal squamous cell carcinoma cells proliferation and invasion via induction of EMT.
    Liu H; Zhen Q; Fan Y
    Int J Biol Markers; 2017 Oct; 32(4):e403-e408. PubMed ID: 28983895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
    Jin L; He Y; Tang S; Huang S
    J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
    Cao S; Liu W; Li F; Zhao W; Qin C
    Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA GHET1 promotes cervical cancer progression through regulating AKT/mTOR and Wnt/β-catenin signaling pathways.
    Liu Z; Luo S; Wu M; Huang C; Shi H; Song X
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31682716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of LncRNA GHET1 expression in various cancers: a systematic review and meta-analysis.
    Ye J; Sun H; Feng Z; Zhang Q; Xia Y; Ji Y; Zhang Q
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31227613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA PCAT6 regulates cell growth and metastasis via Wnt/β-catenin pathway and is a prognosis marker in cervical cancer.
    Lv XJ; Tang Q; Tu YQ; Yan DD; Wei QC
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1947-1956. PubMed ID: 30915737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA GHET1 promotes the development of bladder cancer.
    Li LJ; Zhu JL; Bao WS; Chen DK; Huang WW; Weng ZL
    Int J Clin Exp Pathol; 2014; 7(10):7196-205. PubMed ID: 25400817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of lncRNA GHET1 suppresses cell proliferation, invasion and LATS1/YAP pathway in non small cell lung cancer.
    Guan ZB; Cao YS; Li Y; Tong WN; Zhuo AS
    Cancer Biomark; 2018 Feb; 21(3):557-563. PubMed ID: 29286919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA GHET1 down-regulation suppresses the cell activities of glioma.
    Ni W; Luo L; Zuo P; Li RP; Xu XB; Wen F; Hu D
    Cancer Biomark; 2018; 23(1):9-22. PubMed ID: 30103301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of long non-coding RNA GHET1 suppresses cervical carcinoma in vitro and in vivo.
    Ling W; Yangchun X; Wei W; Qiang W
    Cancer Biomark; 2020; 28(1):21-32. PubMed ID: 32176622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological Significance of Long Non-Coding RNA GHET1 in Human Cancers: A Meta-Analysis.
    Poursheikhani A; Nokhandani N; Yousefi H; Rad DM; Sahebkar A
    Curr Pharm Biotechnol; 2020; 21(14):1422-1432. PubMed ID: 32720600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of long noncoding RNA GHET1 inhibits cell‑cycle progression and invasion of gastric cancer cells.
    Xia Y; Yan Z; Wan Y; Wei S; Bi Y; Zhao J; Liu J; Liao DJ; Huang H
    Mol Med Rep; 2018 Sep; 18(3):3375-3381. PubMed ID: 30066922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Expression Levels of Long Non-Coding RNA, Loc554202, Are Predictive of Poor Prognosis in Cervical Cancer.
    Chen J; Zhu J
    Tohoku J Exp Med; 2017 Nov; 243(3):165-172. PubMed ID: 29129878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of long non-coding RNA expression profiles in lymph node metastasis of early-stage cervical cancer.
    Shang C; Zhu W; Liu T; Wang W; Huang G; Huang J; Zhao P; Zhao Y; Yao S
    Oncol Rep; 2016 Jun; 35(6):3185-97. PubMed ID: 27035672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability.
    Yang F; Xue X; Zheng L; Bi J; Zhou Y; Zhi K; Gu Y; Fang G
    FEBS J; 2014 Feb; 281(3):802-13. PubMed ID: 24397586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.